Dual-Action Nasal Spray Outperforms Steroid Alone in Chronic Blockage Trial
A US trial found a spray combining oxymetazoline and budesonide eased chronic nasal congestion in 83% of patients, versus 36% on steroid alone.
Nov 7, 2026 · 4 min read
114 views